Vestal Point Capital’s Black Diamond Therapeutics BDTX Stock Holding History

Vestal Point Capital’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-870,000	Closed	-$2.11M	–	95
2025 Q4	$2.11M	Sell	870,000 -4,680,000	-84%	-$16.6M	0.07%	70
2025 Q3	$21M	Sell	5,550,000 -50,000	-0.9%	-$146K	0.95%	40
2025 Q2	$13.9M	Hold	5,600,000	–	–	0.73%	41
2025 Q1	$8.68M	Hold	5,600,000	–	–	0.62%	38
2024 Q4	$12M	Buy	5,600,000 +571,500	+11%	+$1.64M	0.71%	40
2024 Q3	$21.9M	Buy	5,028,500 +2,928,500	+139%	+$15.9M	1.66%	22
2024 Q2	$9.79M	Buy	+2,100,000	New	+$11.3M	0.73%	35

Other funds holding BDTX

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Mackenzie Financial

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return